Real-time enrollment status for this prostate cancer clinical trial
Current Status
Recruiting
Checked: April 17, 2026 at 3:26 AM UTC
| NCT Number | NCT02960022 |
| Recruiting Status | Recruiting |
| Condition | Prostate Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 900 participants |
| Active Locations | 50 sites in the US |
| Sponsor | Astellas Pharma Global Development, Inc. |
| Last Updated on CT.gov | April 13, 2026 (4 days ago) |
As of April 17, 2026: Clinical trial NCT02960022 is currently recruiting participants. This clinical trial study for prostate cancer is actively seeking new participants at 50 locations across the United States. The study is sponsored by Astellas Pharma Global Development, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT02960022 is actively recruiting participants as of April 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 50 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT02960022 was last updated 4 days ago (April 13, 2026). HelloStudys verifies this status automatically.